-
1 . Academic Journal
Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton's Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B Cell Malignancies.
- 저자
- by Robbins, Daniel W.; Noviski, Mark A.; Tan, Ying Siow; Konst, Zef A.; Kelly, Aileen, et al.
- 소스
- Journal of Medicinal Chemistry; 2/22/2024, Vol. 678 Issue 4, p2321-2336, 16p
-